Key facts
- Heading’s last known valuation is $3.3M (Feb 2021).
- It has raised $16.3M; the latest was Later Stage VC ($1.5M) in Oct 2025.
- Notable investors include Alumni Ventures, Mana Ventures, Global Brain, Gaingels, Western Technology Investment — 29 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 29 names
- ·Watchlist + deal alerts for Heading
- ·The full record, as it builds
Funding rounds
No funding rounds for Heading are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Heading
Developer of a mental health platform intended to improve access to convenient and accessible mental health care. The company's platform delivers personalized treatment services that leverage evidence-based therapeutics and technologies, transcranial magnetic stimulation, telepsychiatry, and intramuscular ketamine, enabling patients to notice meaningful outcomes and achieve mental well-being through effective and affordable treatments.
- Sector
- Healthcare
- HQ
- Austin, TX, United States
- Founded
- 2020
- Employees
- 47
- Website
- headinghealth.com/
- Ownership
- Privately Held (backing)
Heading doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Heading shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Heading in its N-PORT filings yet. We sweep new filings monthly.